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Retinoic acid (RA) is present at sites of neurogenesis in both the embryonic and adult brain. While it is widely
accepted that RA signaling is involved in the regulation of neural stem cell differentiation, little is known about
vitamin A utilization and biosynthesis of active retinoids in the neurogenic niches, or about the details of retinoid
metabolism in neural stem cells and differentiating progenies. Here we provide data on retinoid responsiveness
and RA production of distinct neural stem cell/neural progenitor populations. In addition, we demonstrate
differentiation-related changes in the expression of genes encoding proteins of the retinoid machinery, including
components responsible for uptake (Stra6) and storage (Lrat) of vitamin A, transport of retinoids (Rbp4, CrbpI,
CrabpI-II), synthesis (Rdh10, Raldh1-4), degradation of RA (Cyp26a1-c1) and RA signaling (Rara,b,c, Rxra,b,c). We
show that both early embryonic neuroectodermal (NE-4C) stem cells and late embryonic or adult derived radial
glia like progenitors (RGl cells) are capable to produce bioactive retinoids but respond differently to retinoid
signals. However, while neuronal differentiation of RGl cells can not be induced by RA, neuron formation by
NE-4C cells is initiated by both RA and RA-precursors (retinol or retinyl acetate). The data indicate that en-
dogenous RA production, at least in some neural stem cell populations, may result in autocrine regulation of
neuronal differentiation.
Introduction
All-trans retinoic acid (RA), a derivative of vitamin A,is one of the most powerful morphogens governing
the development of various tissues and organs, including
the central nervous system. RA has been reported to regulate
neuron formation both in the embryonic, as well as in the
postnatal/adult brain [1–4] and has been widely used as a
potent inducer of neuronal differentiation in various multi-
potent cell populations (embryonic carcinoma cells, embry-
onic and neural stem cells, induced pluripotent stem cells),
in vitro.
The major molecular mechanisms that control RA avail-
ability and signaling were thoroughly characterized over the
last decades [5–9]. In brief, extracellular retinol (ROL) is de-
livered to the tissues via ROL binding protein 4 (RBP4),
which associates with the transthyretin carrier in the circu-
lation (Fig. 1). ROL can be taken up by cells via facilitated
transport upon RBP4-ROL binding to the STRA6 transporter
[10]. Once within the cell, ROL can either be stored after
conversion to retinyl esters (RE) by lecithin retinol acyl-
transferase (LRAT, [11]) or it can be directed towards RA
synthesis. In the latter case, ROL is reversibly converted to
retinaldehyde (RAL) by ROL/alcohol dehydrogenases
(RDHs/ADHs), among which RDH10 seems to play a pri-
mary role [12,13]. RAL is irreversibly oxidized to all-trans RA
by RALDH1-3 retinaldehyde dehydrogenases, while
RALDH4 was shown to be involved in the biosynthesis of
9-cis RA [14]. Oxidation of RA into polar metabolites is me-
diated by CYP26 hydroxylases, a family of cytochrome P450
enzymes. RA exerts most of its effects through activation of
nuclear retinoid receptors, the heterodimers of the RA re-
ceptor (RAR) and the retinoid X receptor (RXR) [8]. All-trans
RA activates RARs and 9-cis RA binds to both RARs and
RXRs [15]. The activated nuclear receptor dimers attach to
RA response elements (RAREs) in the promoter regions of
target genes [8,15,16]. Because of the multiplicity of respon-
sive genes and interacting transcription factors, the actual
actions of RA highly depend on the type, as well as the
physiological and developmental stage of the target cells.
During development, RA plays important regulatory roles
in the formation of the neural tube and regional patterning of
the future hindbrain and spinal cord [1]. Morphogenic roles
of retinoids were also demonstrated in the developing fore-
brain [17–19] and the presence and production of RA was
described in a subdivision of the developing rostro-ventral
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telencephalon, the lateral ganglionic eminence [19–21]. RA-
responsive cells persist in the main neural stem cell niches of
the postnatal rodent brain, including the subventricular zone
(SVZ) adjacent to the lateral ventricles and the dentate gyrus
of the hippocampal formation [2–4,22–24]. Depletion of RA in
adult mice was shown to result in significantly decreased
neuronal differentiation within the dentate gyrus [25,26] and
RA synthesis seems to regulate proliferation and gene tran-
scription of at least a subset of neural stem cells in the SVZ
[27,28]. Most likely, RA signaling can determine the fate of
resident neural stem cells throughout life. However, despite
the accumulating knowledge on RA’s action, the contribution
of intracerebral production and distribution of retinoids to the
genesis and renewal of neural tissue still needs to be specified.
The aim of the present work was to investigate the reti-
noid sensitivity of distinct neural stem/progenitor popula-
tions and to map the expression of retinoid metabolism
related genes during their in vitro neuronal differentiation.
For this purpose, neural stem cells cloned from early em-
bryonic (E9) mouse neuroectoderm (NE-4C cells; [29–34])
and stem/progenitor cells isolated from late embryonic
(E14.5) or adult (P62) neurogenic zones (RGl cells; [35]) were
used. The results demonstrated that the investigated stem/
progenitor populations showed significant differences in
many aspects of both RA metabolism and retinoid respon-
siveness. Each neural stem cell population generated bioac-
tive retinoids capable of activating the RARE-lacZ reporter
transgene from precursor (RE, ROL) molecules, while the
initiation of neuronal differentiation via RA signaling was
restricted to NE-4C neural stem cells.
Materials and Methods
NE-4C neuroectodermal stem cells
NE-4C cells (ATCC no.: CRL-2925; [32]) derived from the
anterior brain vesicles of p53 deficient 9 day old mouse
embryos were maintained in serum containing medium,
composed of minimum essential medium (MEM; Sigma-
Aldrich) supplemented with 5% fetal calf serum (FCS; In-
vitrogen-Gibco), 4 mM glutamine (Sigma-Aldrich) and
40 mg/mL gentamycin (Chinoin), at 37C temperature with
5% CO2. For maintenance, subconfluent cultures were reg-
ularly split by trypsinization (0.05 w/v% trypsin in PBS) into
poly-L-lysine-coated Petri dishes. Neural differentiation was
induced either by addition of RA/ROL/RE (see Results) or
by changing the maintenance medium to defined medium
(DM), formulated as MEM/F12 [1:1] supplemented with
insulin–transferrin–selenite cocktail (Invitrogen-Gibco).
Radial glia-like cells
Radial glia like (RGl) cells were isolated from late
embryonic/fetal (E14,5–16) or adult (P50-180) mouse brains
via selective attachment to adhesive surfaces covered with
FIG. 1. Retinoid metabolism. In the circulation, ROL is bound to RBP4. It can be taken up by cells by facilitated transport via
STRA6 receptors. Within the cell, ROL is carried by CRBPs and can be stored in the form of REs or converted to RA in a two
step process. RA is transported to the nucleus upon binding to CRABPs and acts through the activation of RA receptor
heterodimers. Excess RA can be metabolized by the CYP26 enzymes. RE, retinyl ester; RAL, retinaldehyde; ROL, retinol; RA,
retinoic acid; RBP4, retinol binding protein 4; STRA6, receptor for the ROL/RBP4 complex; CRBP, cellular ROL binding
protein; CRABP, cellular RA binding protein; ADH, alcohol dehydrogenase; RDH, ROL dehydrogenase; RALDH, re-
tinaldehyde dehydrogenase; REH, retinyl ester hydrolase; LRAT, lecithin ROL acyltransferase; RAR, RA receptor; RXR,
retinoid X receptor; CYP26, a family of cytochrome P450 (CYP) enzymes.
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AK-cyclo[RGDfC] peptides [36], as described previously
[35]. The RGl clones used in the presented experiments
were prepared either from late embryonic (E14.5) fore-
brains (RGl-1 and A2 clones) or from the SVZ (SVZ_M
clone) or hippocampus (HC_A clone) of adult (P62) mouse
brain [35].
The cells were maintained in DM composed of DMEM/F12
[1:1] (Sigma-Aldrich), 1% (v/v) B27 (Invitrogen-Gibco) and
20 ng/mL epidermal growth factor (EGF) (Peprotech) (EGF+ ).
According to the aim of the experiment, B27 supplement
without (DM) or with retinyl acetate (DM+RE) [37,38] was
used. For large-scale neuron-production, EGF was withdrawn
(EGF- ) from the media of confluent cultures of RGl cells.
Treatment with retinoids and RAR antagonist
Neural stem cells were treated for varying periods with
various concentrations of retinoids according to the actual
experimental design. NE-4C cells collected for RT-PCR or
real-time PCR were treated with 100 nM all-trans RA (Sigma-
Aldrich) for an initial 48 h. In other experiments retinoids in
100 nM–10mM concentrations were applied for 48 h or on
every 2nd day. The pan RAR antagonist AGN193109 (Al-
lergan, Inc.) was applied daily, at a final concentration of
100 nM [24]. In experiments using retinoids, the cultures and
samples were protected from light.
RA reporter bioassay
The level of biologically active retinoids was determined by
RA reporter cells as described previously [24]. In brief, F9
embryonic carcinoma cells, carrying a RARE-lacZ construct
[39] were maintained in DMEM containing 10% FCS, in the
presence of 400mg/mL G418 (Sigma-Aldrich). F9 cells, plated
24 h before the onset of the experiments in 50,000 cell/cm2
density, were treated with media conditioned by stem cells for
24 h. In other experiments, F9 cells were seeded on top of
confluent layers of neural stem cells to detect the actual reti-
noid production. After 18 h, the cultures were homogenized
and the b-galactosidase activity of the homogenates was de-
termined by the chromogenic substrate ortho-nitrophenyl-b-
D-galactopyranoside (Sigma-Aldrich). The optical density was
measured at a wavelength of 420 nm. The data were related to
optical densities of retinoid-free cultures of the reporter cells
(100%) and averages and standard deviations of relative val-
ues (as percentages) were calculated from 6–8 assays. Stu-
dent’s t-test was used to calculate the P-values.
In experiments with NE-4C cells, the culture media were
changed to defined media either lacking retinoids (DM) or
supplemented with 1 mM ROL, RE or RA for the initial 48 h
of differentiation. After induction, the cultures were wa-
shed several times with retinoid free DM and were sub-
jected to the F9 reporter assay on the 8th day. In agreement
with published data [40] and our tests (not shown), RA
used in the 48 h induction period was successfully removed
by the media changes and/or degraded within no more
than 4 days.
RGl cells were maintained in DM supplemented either
with retinoid free or retinyl acetate supplemented B27 for 2
weeks before the F9 bioassays. Then the cells were differ-
entiated by EGF removal and conditioned media were col-
lected on the 7th day of induction.
Immunocytochemical staining and evaluation
of neuron number
Cultures were fixed with 4% paraformaldehyde in PBS at
room temperature for 20 min. Before staining, the cells were
treated with 0.1% Triton X-100 in PBS for 5 min. After per-
meabilization, nonspecific antibody binding was blocked by
incubating with 5% FCS in PBS (PBS-FCS) for 1.5 h at room
temperature. Primary antibodies were diluted in PBS-FCS and
were used at 4C, overnight. Monoclonal antibodies against
neuron-specific b-III tubulin or GFAP (Sigma-Aldrich) were
diluted in 1:2,000. For fluorescent detection, Alexa-488 and
Alexa-594 conjugated secondary antibodies (Invitrogen) were
used at 1:1,000 dilutions, for 60 min at room temperature.
Independent experimental series and subsequent im-
munostainings were performed at least four times. The anal-
ysis of the images (15 image/culture, 10·objective, Zeiss
Axiovert 200M microscope) was performed by using Ax-
ioVision 4.8 and ImageJ softwares. As an alternative ap-
proach, the number of neurons (b-III tubulin positive cells)
and the total number of DAPI stained nuclei were manually
counted on 15 images taken from each of four parallel cultures
grown in the presence or absence of retinoids or RAR antag-
onist for 4 days. The percentages of neurons were calculated
for each culture, and were averaged among identical treat-
ment-groups. Averages and standard deviations were related
to those obtained from retinoid free, control cultures. Stu-
dent’s t-test was used to calculate the P-values.
Microarray
Samples were collected from noninduced or RA-induced
NE-4C cells being at the 1st, 3rd, 6th and 10th day of differ-
entiation. The cells were grown in the standard MEM medium
complemented with 5% FCS. The RNA integrity was checked
with Agilent 2100 Bioanalyzer. The generation of cDNA, pro-
duction of labeled cRNA, and hybridization to Agilent G4120A
Mouse Development Microarrays were performed according
to standard protocols provided by the manufacturer at the
Microarray Core Facility at the Department of Genetics, Cell-
and Immunobiology at Semmelweis University (Budapest,
Hungary). All materials were purchased from Agilent (Agilent
Technologies) except RNA isolation kit (Qiagen).
RT-PCR analysis
Total RNA was isolated from cells with Tri Reagent (Sigma-
Aldrich) according to the manufacturer’s protocol. DNA
contamination was eliminated by DNase-I (Fermentas) treat-
ment and RNA fraction was dissolved in RNase/DNase free
water at a concentration of 1 mg/mL. Reverse transcription
reactions were undertaken from 3mg total RNA using First
Strand cDNA Synthesis Kit (Fermentas). The quantity of the
cDNA product was determined by PCR (Hotstart Taq PCR
Kit; Qiagen) using the hypoxanthine phosphoribosyltransfer-
ase 1 (Hprt1) coding gene. For each primer pair (see table
below), the PCR conditions (temperatures, cycle numbers and
MgCl2 concentration) have been optimized. The PCR products
were analysed by electrophoresis on agarose gel with ethi-
dium bromide, and were visualized by UV trans-illumination.
The presented RT-PCR results are representatives of sev-
eral independent experiments. In NE-4C cells five completely
different series, while in the case of RGl cells six independent
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(three embryonic and three adult derived) clones were in-
vestigated. For negative control ( - ) water, for positive con-
trols total brain tissue of newborn mice (Lrat, Stra6, Math2,
Ngn2, Oct4, Gfap), cultured astrocytes (Raldh1, Raldh2, RARb,
Cyp26a1) or adult liver tissue (all other genes) were used. As
molecular weight marker (M), GeneRuler DNA Ladder
Mix (#SM0331, Fermentas) was used.
Gene Sense and antisense primers
CrabpI 5¢acgccatgctgaggaaggtgg3¢ and
5¢cctgcatttgcgtccgtccac3¢
CrabpII 5¢tgatgaggaagatcgctgtg3¢ and 5¢ttccactctc
ccatttcacc3¢
CrbpI 5¢ccaaaatgcctgtggactt3¢ and 5¢cttgcagatca
caccctcag3¢
Cyp26a1 5¢gaggggagagaggctggata3¢ and 5¢cagt
ggggcttgtcttcatt3¢
Cyp26b1 5¢ttctctctgccagtggacct3¢ and 5¢cagcacag
cagggtgtttta3¢
Cyp26c1 5¢ttggtacagggctctcgttt3¢ and 5¢atcacctgg
ctctgctgtct3¢
Gfap 5¢gactatcgccgccaactgc3¢ and 5¢cgtccttgt
gctcctgcttc3¢
Hprt1 5¢cacaggactagaacacctgc3¢ and 5¢gctg
gtgaaaaggacctct3¢
Lrat 5¢ctgaccaatgacaaggaacgcactc3¢ and 5¢ctaa
tcccaagacagccgaagcaagac3¢
Math2 5¢tgagaatggcttgtccagaagg3¢ and 5¢tggtagg
gtgggtagaatgtgg3¢
Ngn2 5¢aagaggactatggcgtgtgg3¢ and 5¢atgaa
gcaatcctccctcct3¢
Oct4 5¢ggcgttctctttggaaaggtgttc3¢ and 5¢ctcgaac
cacatccttctct3¢
Rdh10 5¢ acttgtgacgtggggaagag3¢ and 5¢ caaggta
agggcaaaccaga3¢
Raldh1 5¢gccagcagagcaaactcct3¢ and 5¢tcgctcaa
cactccttttca3¢
Raldh2 5¢acatcgatttgcagggagtc3¢ and 5¢gtccaagt
cagcatctgcaa3¢
Raldh3 5¢cgaagagtgcgaaccagtta3¢ and 5¢cttggtga
acttgacctcca3¢
Raldh4 5¢ggaacgttctctcgtcctga3¢ and 5¢gggacacct
gctttatccaa3¢
Rara 5¢gcgagctcattgagaaggtt3¢ and 5¢gtgtcttgct
caggcgtgta3¢
Rarb 5¢ttcaaagcaggaatgcacag3¢ and
5¢gctgggtcgtcgttttctaa3¢
Rarc 5¢ctgcaagggcttcttcagac3¢ and 5¢ctggcaga
gtgagggaaaag3¢
Rbp4 5¢ccgagtcaaggagaacttcg3¢ and 5¢attggg
gtcacgagaaaaca3¢
Rxra 5¢ctcctatcagcaccctgagc3¢ and 5¢accccatagt
gtttgcctga3¢
Rxrb 5¢tgggggtgagaaaagagatg3¢ and 5¢gagcgac
actgtggagttga3¢
Rxrc 5¢tgtgtacagctgtgaaggttgc3¢ and 5¢tctgagaa
gtgggggatgc3¢
Stra6 5¢gcctccctgcctctacttct3¢ and 5¢gccagcaggta
ggagacatc3¢
RNA isolation for real-time PCR
Total RNA was isolated using RNAzol RT solution (Mo-
lecular Research Center Inch.) according to the manufactur-
er’s protocol. Although intron-spanning primer pairs (see
table below) were used in the Real-Time PCR experiments,
genomic DNA contamination was regularly checked by
Real-Time PCR using ACTB (beta-actin) primers on 100 ng
total RNA templates. The RNA samples were considered to
be free of genomic DNA contamination, when CT-s was
higher, than cycle 35. To remove DNA contamination, re-
combinant DNase treatment was carried out using rDNase
set (Macherey-Nagel) then the samples were subsequently
cleaned and concentrated using NucleoSpin RNA Clean-up
XS kit (Macherey-Nagel) according to the manufacturer’s
protocol. The quantity and quality of the RNA were checked
by spectrophotometry and gel electrophoresis.
Target Primer sequence CC Amplicon (nt)
Hprt1 tcctcctcagaccgctttt 900 nM 90
cctggttcatcatcgctaatc 900 nM
Gfap cgccacctacaggaaattg 300 nM 60
gtctgtacaggaatggtgatgc 900 nM
Oct4 gaggctacagggacacctttc 300 nM 71
gtgccaaagtggggacct 300 nM
Ngn2 acatctggagccgcgtag 900 nM 79
cagcagcatcagtacctcctc 900 nM
Math2 cgacactcagcctgaaaaga 900 nM 155
caaactttctgcacatctggg 900 nM
Stra6 cgaggaacctctaggagctg 900 nM 60
agctggcaaaggggaatc 300 nM
Cyp26a1 ccggcttcaggctacaga 900 nM 125
ggagctctgttgacgattgtt 900 nM
Aldh1a1 ctcctctcacggctcttca 300 nM 71
aatgtttaccacgccaggag 900 nM
Aldh1a2 catggtatcctccgcaatg 900 nM 65
gcgcatttaaggcattgtaac 300 nM
Aldh1a3 aacctggacaaagcactgaag 900 nM 74
aatgcattgtagcagttgatcc 300 nM
Lrat tatggctctcggatcagtcc 300 nM 102
taatcccaagacagccgaag 900 nM
Reverse transcription for real-time PCR
Briefly 2mg total RNA, 200 ng Random Primers (Invitrogen,
Life Technologies), and 1mL dNTP (10 mM each) were com-
bined and incubated for 5 min at 65C. After 2 min chilling on
ice, 200 U SuperScript III Reverse Transcriptase (Invitrogen,
Life Technologies), 40 U RNaseOUT Recombinant Ribonu-
clease Inhibitor (Invitrogen, Life Technologies), and 5 mM di-
thiothreitol were added to the mixture in 20mL reaction
volume. The reaction mixture was incubated at 25C for 10 min
to anneal the random hexamers, at 50C for 5 h to transcribe
cDNA and at 70C for 15 min to inactivate the enzymes.
Relative quantitative real-time PCR assay
1 mL cDNA was used for quantifying mRNA together with
300 or 900 nM intron-spanning primers and 10 mL 2·Power
Syber Green PCR Master Mix (Applied Biosystems). Each
reaction was run in triplicate on differentiating NE-4C (DIV2,
4, 6, 10, 14), embryonic RGl or adult RGl (DIV4, DIV8)
samples, as well as on nondifferentiated NE-4C or RGl
(DIV0) samples. Amplification was performed in StepOne-
Plus (Applied Biosystems) equipment.
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Real-time PCR data evaluation
Data were normalized to hypoxanthine phosphoribosyl-
transferase 1 (Hprt1) gene expression and evaluated with
StepOne Software v2.1 (Applied Biosystems) utilizing the
Relative Quantitative Real-Time PCR assay evaluation with
comparative CT (DDCT) method. The Relative Quantity val-
ues were analyzed with one-way analysis of variance to-
gether with the two-sided Dunnett post-hoc test to evaluate
whether difference in mRNA levels of the given target be-
tween a sample and the reference of means is significant. The
statistics were carried out using the SPSS for Windows 9.0
software. On the diagrams gene expression data of differ-
entiating and undifferentiated stem cells are compared. All
data are presented as Means – SD of the biological parallels
and P-values below 0.1 are shown. Detailed statistical anal-
ysis is shown in Supplementary Table S1; Supplementary
Data are available online at www.liebertpub.com/scd
Results
Retinoid-reponsiveness and the expression of retinoid
metabolism (Fig. 1) related genes were investigated in dif-
ferent neural stem cell populations cloned from embryonic or
adult brain tissues (Table 1) and in their progenies at various
stages of in vitro induced neuronal differentiation.
NE-4C neuroectodermal stem cells (Fig. 2A) were derived
from the anterior brain vesicles of E9 mouse embryos [32]. These
cells display many characteristics of radial neurepithelial cells,
residents of the neural plate and early neural tube, including
Oct4 and Sox2 expression, the lack of Pax6 or proneuronal/
neurogenic (Ngn2/Math2) gene transcription, and the lack of RC2
or GFAP protein production (Fig. 2B and Table 1). If induced by
all-trans RA, NE-4C cells develop into neurons and glial cells
through well characterized stages of differentiation, including
transient states of radial glia like development characterized
with Pax6 and Emx2 expression and RC2-immunopositivity
[29,33,41,42]. Mature neurons with synapsin expression and
specific machinery for neurotransmitter production, release and
uptake develop by the 9–10th day after RA induction [31].
Smaller-scale neuronal differentiation of NE-4C cells was
observed in the absence of exogenous RA too, in response to
growth factor/serum withdrawal. Under such conditions,
however, lesser neurons were formed as it was indicated by
the markedly lower percentage of bIII-tubulin im-
munreactive cells (5.5% – 1% neurons in serum withdrawal
induced cultures versus 25.9%– 1.5% in RA treated cultures)
at DIV4. The difference in neuronal density was more evi-
dent by DIV9 (Fig. 2A) and was further supported by RT-
PCR and real-time PCR data on Ngn2 and Math2 expression
in a longer (14 day) time scale (Fig. 2B–D; Supplementary
Table 1. Characteristics of NE-4C and Radial Glia Like (RGl) Neural Stem Cell Clones
Neural stem/progenitor clones
Characteristics NE-4C cells Radial glia like cells (RGl)
Origin embryonic (E9) anterior
brain vesicles
embryonic (E14,5)
forebrain
adult (P62) SVZ, HC
Principle of isolation continuous proliferation
in serum+medium
selective adhesion to
and serum-free propagation
on AK-c(RGDfC) peptide
Cell cycle time 16 h *20 h 22–24 h
Cytochemical markers nestin + + +
RC2 - + +
GFAP - - +
bIII-tub - - -
Gene expression (based on
RT-PCR data)
Oct4 + - -
Nanog + - -
Sox2 + + +
Pax6 - + +
Blbp + + +
GLAST + + +
Ngn2 - + +
Mash1 - + +
Math2 - - -
Induction of neural
commitment/differentiated
progenies
Retinoic acid or serum
withdrawal (neurons
and astrocytes)*
EGF withdrawal (neurons); serum
supplementation (astrocytes);
PDGF +FGF + forskolin/T3 +AA
(oligodendrocytes)
Undifferentiated NE-4C cells display many embryonic stem cell features (Oct4, Nanog) with complete inactivity of tissue-specifying bHLH
(Ngn2, Mash1, Math2) or radial glia specifying (Pax6, RC2) markers [32,57,58]. Their neural commitment is indicated by the expression of Sox2
[59] and by the fact that they could develop exclusively to neural cell types [60]. The lack of Oct4 and Nanog and the presence of RGl (RC2,
GLAST) immunoreactivities together with the expression of proneural bHLH (Ngn and Mash1) genes indicate that noninduced RGl cells
represent a more advanced progenitor state than NE-4C cells [35].
*Differentiation of NE-4C cells towards the oligodendroglial lineage was observed upon implantation into the lesioned cerebral cortex [61].
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Fig. S1). While transcription of both Ngn2 and Math2 was
upregulated upon serum withdrawal, Ngn2 expression in-
creased with a delay and Math2 expression remained below
the levels observed in RA-induced cultures. Without RA,
transcription of the stem cell specific Oct4 was preserved in
the cultures during the entire course of differentiation
showing only a minor decline, after DIV6 (Fig. 2C). During
RA-induced differentiation Oct4 expression dropped con-
siderably by DIV6 (Fig. 2B, D) followed by a later rise back to
the basal levels by DIV14. The data are in accord with our
FIG. 2. Characteristics of NE-4C neural stem cells and radial glia like (RGl) cells. (A) Phase-contrast view of noninduced
NE-4C cells (Ø) and b- III tubulin immunocytochemical staining of NE-4C derived neurons on the 7th day of induction
(DIV7) (bars: 50 mm). Neuronal differentiation of NE-4C cells was initiated either by serum removal (DM: defined medium) or
by RA treatment (DM +RA). (B) RT-PCR of the expression of some development-related (Oct4 stem cell-specific, Ngn2
proneural, Math2 neurogenic/neuronal and Gfap astrocyte-specific) genes in nondifferentiated (Ø) or differentiated cells. (C,
D) Relative expression of the same genes during differentiation (DIV2–DIV14) compared to noninduced cells (DIV0). (E) The
characteristic elongated morphology of noninduced (EGF + ) adult-derived RGl cells and immunofluorescent stainings of
their neuronal and astroglial derivatives on the 7th day of induction (DIV7) (bars: 20 mm). Differentiation of RGl cells was
induced by EGF withdrawal (EGF - ). (F) RT-PCR demonstration of transcription of Oct4, Ngn2, Math2 and Gfap genes by
embryonic or adult-derived RGl cells. (G, H) Relative expression of the same genes during differentiation (EGF- ; DIV4 and
DIV8) compared to noninduced cells (DIV0). DIV indicates in vitro days after the onset of induction. ‘‘ - ’’and ‘‘ + ’’ represent
the negative (water) and positive (total brain) controls of the RT-PCR reactions. ‘‘M’’ indicates molecular weight marker. All
real-time PCR data are means – SD from triplicate data. EGF, epidermal growth factor; RT, reverse transcription.
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previous findings [34] on the persistence of noncommitted
stem cells in differentiating cultures.
Upon RA-priming, NE-4C stem cells generate neurons and
the gliogenesis is blocked for a 10–12 day period [29]. By the
end of the 2nd week of RA-induction, neurogenesis ceases
and astrocytes appear. Without RA-priming, however,
GFAP-immunpositive astrocytes are not generated at all [29].
The earlier observations together with the recent data on
Gfap expression (Fig. 2C, D) indicate that neuronal differen-
tiation dominates over gliogenesis in the investigated period
of NE-4C cell development.
RGl neural stem/progenitor clones were isolated by their
preferential adhesion to a synthetic polypeptide AK-
c(RGDfC) [36] and by propagation on peptide-coated
surfaces under serum-free conditions with EGF supple-
mentation [35]. Regardless of the age (eg, E14.5 or P62) and
the region of the source brain tissue, peptide-adhering cells
displayed elongated morphology (Fig. 2E), RC2 immuno-
reactivity and expressed Sox2 and Pax6 mRNAs, but did
not transcribe the early pluripotency genes Oct4 and Nanog
[35] (Fig. 2F). They gave rise to Ngn2 and Math2 mRNAs
(Fig. 2G, H) and bIII-tubulin (Fig. 2E) expressing neurons
upon induction by EGF withdrawal, in the absence of ex-
ogenous RA ([35]). Gfap mRNA was present in both em-
bryonic and adult derived RGls cells (Fig. 2F) but GFAP
protein could be demonstrated only in adult derived cul-
tures [35]. Upon EGF withdrawal, the increase of Gfap level
was significantly higher in adult RGl cells than in embry-
onic ones (Fig. 2G, H).
RA-production by NE-4C neural stem cells
and RGl progenitors
As we reported earlier [24], nondifferentiated NE-4C cells
did not produce enough retinoids to activate RA-reporter F9
cells. However, if neuronal differentiation was induced by an
initial 48 h treatment with RA, the cells generated bioactive
retinoids 6 days later, as it was indicated by the RA-reporter
assay (Fig. 3A). RA production, on the other hand, was not
detected if neural differentiation was initiated by serum
withdrawal without RA-treatment.
In contrast to NE-4C cells, nondifferentiated (EGF + ) RGl
cells produced sufficient retinoids to be detected by F9 RA-
reporter cells (Fig. 3B). Cells differentiated upon EGF re-
moval (EGF - , DIV7) produced even higher amounts of RA,
both in embryonic and adult-derived cultures. The potential
for retinoid production, however, seemed to depend on RE
supply in the culture medium.
The different RA production and RA-sensitivity of NE-4C
and RGl cells suggested major differences in their retinoid
machinery. To explore this, we investigated the transcription
of genes encoding enzymes, transporters and storage pro-
teins involved in RA metabolism in both noninduced neural
stem cells and in their differentiating progenies (Table 2 and
see details below).
Expression of elements of the retinoid machinery
in NE-4C cells and RGl cells and in their
differentiating progenies
Uptake and storage of vitamin A. The mRNA of ROL
binding protein (Rbp4), the major extracellular carrier of ROL
[43] was present both in NE-4C and RGl cells, regardless of
the stage of differentiation (Fig. 4A, F). The transcript of the
RBP4 receptor Stra6 [10] was present in nondifferentiated
NE-4C neural stem cells (Fig. 4A). Its expression increased
significantly in response to RA treatment by DIV1-2 (Fig. 4A,
B, D), and decreased thereafter, but remained elevated in
comparison to noninduced cells, even 10 days after the re-
moval of RA (Fig. 4B). Smaller, but significant increase was
observed in Stra6 expression during serum-deprivation in-
duced differentiation too, but with a few day delay (Fig. 4A,
B). The Stra6 transcript was absent from or was expressed at
a very low level in RGl cells (Fig. 4F) and was upre-
gulated appreciably only in differentiating adult RGl clones
(Fig. 4G, I).
FIG. 3. Retinoid production by NE-4C neural stem cells and RGl cells assayed by measuring b-galactosidase activity in F9
RA-reporter cells. (A) NE-4C cells were kept either in DM or treated with 1mM RE, ROL or RA for 48 h (DIV0-2), then washed
thoroughly and kept in retinoid-free medium for 6 more days (DIV2-8). The RA-reporter cell assay was carried out on DIV8
incubating the differentiated NE-4C cells in cocultures with the reporter cells. The method allowed direct, cell to cell
activation of the transgene. *P < 0.01. (B) b-galactosidase response of F9 RA-reporter cells to conditioned media obtained
either from nondifferentiated (EGF + ) or differentiated (EGF- ) embryonic or adult RGl cells grown in the absence (DM) or
presence (DM+RE) of retinyl acetate for at least 2 weeks before, as well as during the assay. The optical density (OD) values
of the assays (A, B) were related to the b-galactosidase activity (100%; indicated by the dashed line) of control F9 cells. *P< 0.01:
significant difference from F9 cells; #P < 0.05: significant difference from cells grown in DM+RE.
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Lrat, the major enzyme responsible for the esterification
and storage of ROL, was transcribed by NE-4C neural stem
cells at all stages of differentiation (Fig. 4A). In the course of
NE-4C cell differentiation its expression showed a minor and
transient decrease in RA-induced cultures, while only a mi-
nor and transient elevation was observed under serum free
conditions (Fig. 4A, C, E). Lrat expression in RGl cells was
around the detection limit and showed only a small decrease
in embryonic and a small increase in adult RGl cells upon
differentiation (Fig. 4F, H, J).
RA synthesis. RA synthesis depends on the presence of
ROL/alcohol (RDHs/ADHs) and RALDHs (Fig. 1) catalyzing
the first and second steps of ROL4RAL/RA conversion,
respectively. ROL dehydrogenase 10 (Rdh10), a prominent
member of the Rdh family [12,13], was present at the mRNA
level in both noninduced and differentiated neural stem cells
regardless of their origin (Fig. 5A, F). Its expression increased
upon induction in NE-4C cell cultures (Fig. 5A). In noncom-
mitted NE-4C cells, only Raldh3 and Raldh4 mRNAs were
detected, as it was shown by RT-PCR (Fig. 5E; [24]). During
differentiation, Raldh1 displayed the highest elevations in ex-
pression among Raldhs as it is indicated by the real-time PCR
data (Fig. 5B–D). Raldh1 and also Raldh2 messages were rap-
idly upregulated (within 24–28 h) upon RA treatment fol-
lowed by a transient decline by DIV6 or DIV4, respectively
(Fig. 5B, C, E). Raldh3 did not respond to RA treatment with
an immediate upregulation but it was slightly increased
during differentiation (Fig. 5D), while Raldh4 mRNA content
was slightly elevated during RA induced differentiation ac-
cording to the RT-PCR data (Fig. 5E). Under serum free con-
ditions, Raldh1 levels increased considerably, with a peak at
DIV6 (Fig. 5B), while Raldh2 and Raldh3 levels decreased
slightly during the 1st week of differentiation and increased
thereafter (Fig. 5C, D).
Raldh1 and Raldh3 mRNAs were present in non-
differentiated RGl cells, while Raldh2 was absent or ex-
pressed at a very low level (Fig. 5F). Real-time PCR data
indicated a slight increase in Raldh1 and Raldh2 expression in
the adult-derived RGl cells, while both Raldh1 and Raldh2
levels dropped by DIV8 in the differentiating embryonic RGl
cells (Fig. 5G, H). A significant downregulation of Raldh3
upon EGF withdrawal was detected in all investigated RGl
cell clones (Fig. 5F–H) and Raldh4 was not found in RGl cells
by RT-PCR (Fig. 5F).
The expression patterns of Raldhs were in accordance with
our earlier [24,29] and recent findings that noncommitted
and differentiating neural stem cells possess the capability to
produce RA.
Intracellular ROL and RA binding proteins. Cellular ROL
binding protein I (CrbpI) mRNA levels increased in NE-4C
neural stem cells after RA exposure, with no apparent
changes in later stages of differentiation. CrbpI level was,
however, not elevated in cultures induced by serum depri-
vation (Fig. 6A). CrbpI mRNA was present in undifferenti-
ated RGl cells (Fig. 6B) too. With the advancement of neural
differentiation, the expression decreased in RGl cells of em-
bryonic origin, while no marked changes were observed in
adult derived cells.
In noncommitted NE-4C cells, CrabpI mRNA was not ex-
pressed, while CrabpII mRNA was present. The mRNA levels
Table 2. Expression of Components of RA Metabolism in NE-4C and RGl Neural Stem Cells
RGl cells
NE-4C cells nondifferentiated differentiated
nondifferentiated differentiated EGF+ EGF -
Function mRNA serum + serum withdrawal retinoic acid e a e a
Uptake and storage Rbp4 + + + + + + +
Stra6 + [ [ - - Y [
Lrat + + Y - - Y [
RA synthesis Rdh10 + [ [ + + + +
Raldh1 - [ [ + + Y [
Raldh2 - Y[ [ - - Y [
Raldh3 + Y[ [ + + Y Y
Raldh4 + + + - - - -
Intracellular transport CrbpI + + [ + + Y +
CrabpI - - [ + +/ - + +/ -
CrabpII + + [ + + + +
RA catabolism Cyp26a1 - [ [ - - - [
Cyp26b1 + + [ - - +/ - -
Cyp26c1 - - [ - - - -
RA receptors Rara + + + + + + +
Rarb - [ [ + + + +
Rarc + + + + + + +
Rxra + + + + + + +
Rxrb + + + + + + +
Rxrc + + + - - - -
‘‘+ ’’ and ‘‘- ’’ indicate the presence or absence of the transcripts; the arrows indicate up- or downregulation of gene expression upon
differentiation, not specifying the magnitude of growth or decrease. The table summarizes the results of real time PCR and RT-PCR data
obtained from several experimental series (see Materials and Methods), represented in Figs. 4–8.
e, embryonic; a, adult.
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of both binding proteins increased after RA treatment with
CrabpI responding more slowly to RA priming and declining
markedly after DIV8 (Fig. 6A). Both CrabpI and II mRNAs
were expressed in all RGl clones at a relatively low level
(Fig. 6B).
RA catabolism. Members of the cytochrome P450 family
26 (Cyp26) enzymes are responsible for metabolizing RA
(Fig. 1). RA treatment of NE-4C cells resulted in a marked
upregulation of Cyp26a1 and Cyp26b1 mRNAs within 12 h
and a moderate increase of Cyp26c1 within 24 h after RA
exposure (Fig. 7A, C). The initial elevations in all Cyp26
mRNA expressions, however, were transient and after
varying periods turned to a decline. A transient but signifi-
cant rise of Cyp26a1 mRNA was observed in NE-4C cells
differentiating without exogenous RA too, with a peak at
DIV6 (Fig. 7A, B). The latter finding may suggest that these
cells produced sufficient amounts of RA to activate the
transcription of the direct RA-responsive Cyp26a1 gene. Al-
ternatively, upregulation of the Cyp26a1 enzyme mRNA
might be explained by turning on some unidentified, RA-
independent and/or developmental stage-related pathways.
In embryonic RGl cells a low level Cyp26b1 expression
was observed, while none of the Cyp26 enzymes could be
detected in adult derived RGl clones by RT-PCR (Fig. 7D).
FIG. 4. RT and real-time PCR
analysis of elements of the retinoid
machinery involved in binding,
uptake and storage of vitamin A
during differentiation of NE-4C
neural stem cells and RGl cells. (A)
Rbp4, Stra6, and Lrat expression in
NE-4C cells demonstrated by RT-
PCR. Neuronal differentiation of
the NE-4C cells was initiated either
by serum removal (DM) or by RA
treatment (DM +RA). (B, C) Real-
time PCR analysis of Stra6 and Lrat
expression during a 2-week period
in NE-4C cells. (D, E) RT-PCR of
Stra6 and Lrat in the first 44 h after
the onset of induction of NE-4C
cells with RA. (F–J) RT-PCR (F) and
real-time PCR (G–J) analysis of
Rbp4, Stra6 and Lrat expression in
nondifferentiated (EGF + ) and dif-
ferenting (EGF- ) embryonic (G, H)
and adult (I, J) RGl cells. DIV and
Hrs indicate in vitro days and
hours, respectively, after the onset
of induction. ‘‘ - ’’and ‘‘ + ’’ represent
the negative (water) and positive
(brain, liver) controls of the RT-PCR
reactions. ‘‘M’’ indicates molecular
weight marker. All real-time PCR
data are means – SD from triplicate
data. *P < 0.05; #P = 0.064.
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By real-time PCR, low level activation of Cyp26a1 was re-
vealed during the differentiation of adult-derived RGl cells
(Fig. 7E, F).
RA receptors. Multiple RAR and RXR subunits were ex-
pressed by both NE-4C and RGl cells (Fig. 8A, C). Rarb
mRNA level, however, was extremely low in non-
differentiated NE-4C neural stem cells (Fig. 8A) and Rxrc
mRNA was missing from all RGl cell populations (Fig. 8C).
EGF withdrawal-induced differentiation of the RGl cells was
not accompanied by consistent changes in the expression of
retinoid receptors, when several clones were investigated
(from which Fig. 8C represents only one embryonic and one
adult clone). In NE-4C cells, however, the Rarb message in-
creased rapidly (within 12 h, data not shown) in response to
FIG. 5. RT and real-time PCR
analysis of genes involved in the
synthesis of RA during differentia-
tion of NE-4C neural stem cells and
RGl cells. (A) Expression of Rdh10
demonstrated by RT-PCR both in
nondifferentiated (Ø) and differen-
tiating NE-4C cells. Differentiation
was induced either by serum with-
drawal (DM) or RA treatment
(DM +RA). (B–E) Expression of
Raldh1-4 in differentiating NE-4C
cells demonstrated by real-time
PCR (B–D) in the first 2 weeks and
by RT-PCR assays (E) in the first
44 h after the onset of induction. (F–
H) RT-PCR (F) and real-time PCR
(G, H) analysis of Rdh10 and
Raldh1-4 expression in non-
differentiated (EGF + ) and differ-
entiating (EGF- ) embryonic (G)
and adult (H) RGl cells. DIV and
Hrs indicate in vitro days and
hours, respectively, after the onset
of induction. ‘‘ - ’’ and ‘‘ + ’’ repre-
sent the negative (water) and posi-
tive (liver, glia) controls of the RT-
PCR reactions. ‘‘M’’ indicates mo-
lecular weight marker. All real-time
PCR data are means – SD from
triplicate data. *P < 0.05; #P = 0.058;
P = 0.071.
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FIG. 6. RT-PCR analysis of genes
involved in the intracellular bind-
ing of ROL and RA in NE-4C neural
stem cells and RGl cells. (A) RT-
PCR analysis of CrbpI and CrabpI-II
in nondifferentiated (Ø) and differ-
entiating NE-4C cells. Differentia-
tion was induced either by serum
withdrawal (DM) or RA treatment
(DM+RA). (B) RT-PCR analysis of
CrbpI and CrabpI-II expression in
nondifferentiated (EGF+ ) and dif-
ferentiating (EGF- ) RGl cells. DIV
indicates in vitro days after the
onset of induction. ‘‘ - ’’ and ‘‘ + ’’
represent the negative (water) and
positive (liver) controls of the RT-
PCR reactions. ‘‘M’’ indicates mo-
lecular weight marker.
FIG. 7. RT and real-time PCR
analysis of genes involved in the
catabolism of RA in NE-4C neural
stem cells and RGl cells. (A–C) Ex-
pression of Cyp26a1, Cyp26b1, and
Cyp26c1 enzyme mRNAs demon-
strated by RT-PCR (A, C) and real-
time PCR (B) both in non-
differentiated (Ø) and differentiated
NE-4C cells. Differentiation of the
cells was induced either by serum
withdrawal (DM) or RA treatment
(DM +RA). (D–F) RT-PCR (D) and
real-time PCR (E, F) analysis of
Cyp26a1-c1 enzyme expression in
nondifferentiated (EGF + ) and dif-
ferentiated (EGF - ) RGl cells. DIV
and Hrs indicate in vitro days and
hours, respectively, after the onset
of induction. ‘‘ - ’’ and ‘‘ + ’’ repre-
sent the negative (water) and posi-
tive (liver, glia) controls of the RT-
PCR reactions. ‘‘M’’ indicates mo-
lecular weight marker. All real-time
PCR data are means – SD from
triplicate data. *P < 0.05; #P = 0.06;
P = 0.097.
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induction regardless whether it was initiated with RA or
serum deprivation, as it was shown both by RT-PCR (Fig.
8A) and microarray data (Fig. 8B). Rarb expression declined
considerably in later stages of serum withdrawal (Fig. 8A)
and slightly during RA induced (Fig. 8A, B) differentiation.
Responsiveness of neural stem cells
to RA-precursor molecules, ROL and retinyl acetate
ROL induces robust neuronal differentiation in NE-4C neural
stem cells. As genes encoding the components of the uptake
and storage of vitamin A and the key enzymes of RA syn-
thesis were active in noninduced NE-4C cells, we raised the
question whether RA can be replaced by RA precursors in
inducing neural differentiation. ROL or retinyl-acetate (RE)
was added to the cells and neuron formation was followed
by immunocytochemical staining for neuron-specific b-III
tubulin on the 3rd, 5th, 7th, and 9th days after retinoid ad-
dition (Fig. 9A, B). b-III tubulin immunoreactive neurons
appeared in RA-primed cultures as early as the 3rd day of
induction. Large scale neuron formation in ROL treated
cultures was observed from the 5th day on. In RE treated or
retinoid free cultures massive neuron formation was de-
tected not sooner than the 7–9th days (Fig. 9A), but the
neuron density did not reach the levels observed in RA or
ROL treated cultures (Fig. 9B). Counting b-III tubulin im-
munopositive neurons revealed that all investigated reti-
noids significantly elevated the neuron number if applied for
4 days. Compared to retinoid free control cultures (100%–
19%), the percentage of neurons was 159% – 24% in RE,
179% – 29% in ROL and 499%– 29% in RA treated cultures
(Fig. 9C). Neuron forming effects of all retinoids were com-
pletely prevented if the pan RAR antagonist AGN193109
was included in the culture media during the 1st day of
induction demonstrating that the induction was mediated
through nuclear retinoid receptors regardless if it was initi-
ated by RA, ROL, or RE. The antagonist was effective in the
initial 48 h period of retinoid application, but did not arrest
neuron formation if applied later (Fig. 9C).
The schedule of differentiation was monitored also by real
time PCR and RT-PCR analysis of differentiation marker
gene expression (Supplementary Fig. S1). Real-time PCR
data showed an order of DM +RA >DM+ROL >DM +RE >
DM in both the magnitude and timing of the activation of
proneural Ngn2 and neurogenic/neuronal Math2 genes
(Supplementary Fig. S1). The statistical analysis of the data
revealed, that RE induced cells express significantly more
Ngn2 (P < 0.005) at DIV2 and Math2 mRNAs (P < 0.005) at
DIV4 than cells differentiating in retinoid free DM, indicating
that RE, probably through conversion to RA, had an influ-
ence on gene expression too, even if the increase in neuron
number in RE containing medium lagged behind that of
FIG. 8. RT-PCR and microarray
analysis of RARs and RXRs in NE-
4C neural stem cells and RGl cells.
(A) Expression of Rar and Rxr
mRNAs were demonstrated both in
nondifferentiated (Ø) and differen-
tiating NE-4C cells by RT-PCR. (B)
Microarray data show the expres-
sion of retinoid receptor subunits in
differentiating cells compared to
undifferentiated ones. Differentia-
tion was induced either by serum
withdrawal (DM; A) or RA treat-
ment either in DM (DM +RA; A) or
in serum containing medium
(SM +RA; B). (C) RT-PCR analysis
of Rar and Rxr receptor expression
in nondifferentiated (EGF+ ) and
differentiating (EGF - ) embryonic
and adult-derived RGl cells. DIV
and Hrs indicate in vitro days and
hours, respectively, after the onset
of induction. ‘‘ - ’’ and ‘‘ + ’’ repre-
sent the negative (water) and posi-
tive (liver, glia) controls of the RT-
PCR reactions. ‘‘M’’ indicates mo-
lecular weight marker.
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ROL. The induction of neuronal differentiation by different
retinoids was concentration-dependent. RA initiated neuro-
nal differentiation effectively in a concentration as low as
1 pM when applied under serum free conditions [24], while
ROL and RE induced neuron formation in 100 nM and 1mM
doses, respectively (Supplementary Fig. S2). Higher concen-
trations resulted in formation of more compact aggregates
with higher neuron density (Supplementary Fig. S2A).
Application of RA precursors evoked changes in the ex-
pression of genes of the retinoid machinery too. Raldh1 and
FIG. 9. Diverse responses of NE-4C neural stem cells and RGl cells to retinoids. (A)Neuron-specificb-III tubulin immunoreactive
neurons in cultures of NE-4C cells grown for 3, 5, 7 or 9 days (DIV) either in retinoid free DM or in media supplemented with 1mM
RE, ROL or RA. (B) Densitometric analysis of fluorescence in cultures (n= 4) represented in (A). The data were normalized to
the average OD of cultures grown in retinoid free DM for 3 days (100%). (C) Percentage of neurons in cultures induced by 1mM
RE, ROL or 10 nM RA and grown in the presence or absence of 100 nM pan RAR antagonist AGN193109 for various periods
(DIVstarting-ending). The percentages of neurons were determined inb-III tubulin immunostained preparations (n= 4 for each) fixed on
the 4th day. The data were related to the percentage of neurons in cultures grown in retinoid and antagonist free DM (100%, DM Ø).
DIV indicates in vitro days after the onset of induction. *P< 0.05. (D)b-III tubulin immunoreactive neurons in cultures of embryonic
and adult-derived RGl cells grown (EGF+ ) or differentiated (EGF- ) in the absence or presence of different retinoid (1mM RE, ROL,
RA) supplements for 4 days. (E, F) Percentage of neurons in cultures grown in 1mM RE, ROL, RA, or 100 nM RAR antagonist
containing media for 4 days. The percentages of neurons were determined in b-III tubulin immunostained preparations (n= 4 for
each) fixed on the 4th day. Data obtained from control (retinoid and antagonist free) cultures were set to 100%. Scale bars: 100mm.
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Stra6 mRNAs were significantly upregulated in the pres-
ence of ROL (Supplementary Fig. S1). The expression of
Cyp26 enzymes, known to be directly regulated by RA [44],
was increased by both ROL and RE. In RE containing me-
dium the peak of Cyp26a1 mRNA expression was at DIV6,
while in ROL or RA around DIV4 and DIV2, respectively
(Supplementary Fig. S1; Fig. 7A, C). Rarb, another direct RA-
response gene [45,46] showed similar quick activation in re-
sponse to ROL, RE (Supplementary Fig. S1) and RA (Fig. 8A).
While the cellular responses to ROL (and RE) indicated an
effective conversion of the precursor molecules to active reti-
noids, significant retinoid-activity in the fluid environment of
RE or ROL treated NE-4C cells could not be detected by the F9
RARE-lacZ reporter cell line (Fig. 3A). These data, however,
did not exclude the possibility that ROL- or RE-induced NE-4C
cells produced small amounts of RA sufficient to initiate
neuronal differentiation but this amount of RA, if dissolved in
the large volume of culture medium, is below the detection
limit (1 nM, [24]) of the reporter assay. This assumption was
supported by the fact that the RAR-antagonist AGN193109
could effectively block the ROL-induced differentiation even in
a concentration as low as 100 pM (Supplementary Fig. S2B).
RGl cells do not differentiate in response to retinoids. To in-
vestigate the influence of retinoids on neuronal differentiation
of RGl cells, we treated the cultures with 1mM RE, ROL, or RA.
In the presence of EGF, neuronal differentiation could not to be
initiated by any of the retinoids as it was demonstrated by the
complete lack of b-III tubulin expression (Fig. 9D). Besides, in
RGl cell cultures differentiating in response to EGF withdrawal,
the percentage of neurons was not altered by either retinoid or
RAR antagonist treatment (Fig. 9D–F). Meantime, significant
retinoid production by both embryonic and adult derived RGl
cells was detected with F9 RA-reporter cells (Fig. 3B).
In experiments presented in Fig. 9D–F, RGl cells were
maintained in retinoid-free medium for at least 2 weeks be-
fore addition of exogenous retinoids. Retinoid depletion,
however, did not affect the neurogenic capacity of the cells.
These findings were further supported by experiments, when
RGl cells isolated from adult brains (P153, SVZ) were pre-
pared and maintained in DM lacking retinoids for more than
2 month. The neurogenic capacity of these cells was main-
tained under such conditions too (data not shown). These
observations together with the inability of the pan RAR an-
tagonist AGN193109 to prevent neuronal differentiation (Fig.
9E, F) demonstrated that endogenous RA synthesis did not
contribute to enhanced neurogenesis in RGl cells.
Discussion
A number of recent investigations have demonstrated
that RA-responsive cells are present not only in the devel-
oping rodent brain but they also persist in the neural stem
cell niches in the postnatal CNS [2,3,22–24]. Retinoids are
known to regulate many aspects of neural cell develop-
ment, including regional and phenotype-determination
[47], gliogenesis [29], neurite growth [48], and synaptic
functions [49]. Discussing the influence of retinoids on fine-
tuning of neural cell type specification is beyond the scope
of this article. The presented data, however, clearly indicate
that distinct neural stem cell/progenitor populations re-
spond to retinoids in diverse ways. The major similarities
and differences between the investigated NE-4C and RGl
stem cell populations in the context of their developmental
potential, retinoid responsivity and metabolism are sum-
marized in Tables 1–3.
In NE-4C cells, despite of hardly measurable levels of RA
production, ROL and RE initiated differentiation and acti-
vated RA-responsive (Cyp26a1, Rarb [44–46]) genes. Delays in
neuron formation and gene activation suggested a rather
slow accumulation of active retinoids upon RE/ROL-
induction. Even low (picomolar) levels of RA, however, can
initiate neural development of NE-4C cells [24], similarly to
ES cells [47]. The lack of catabolising Cyp26 enzymes might
contribute to high RA-responsiveness of noninduced NE-4C
cells. During differentiation, Cyp26 enzymes are upregulated,
but while balancing the intrinsic RA level, they may generate
4-oxo- and 4-hydroxy-RA compounds, known to contribute to
the differentiation of ES [50] and neural progenitor [51] cells.
In contrast to NE-4C stem cells, RGl cells produced sig-
nificant amounts of RA, but displayed RA-independent dif-
ferentiation program. The rate of neuronal differentiation of
these cells was not affected either by the application of reti-
noids or RAR-antagonist. Also, RGl cells, which were pre-
pared and maintained for several weeks in retinoid free
Table 3. Major Similarities and Differences Between
NE-4C and RGl Cells in the Context of Their Retinoid
Responsivity, Production and Metabolism
Similarities
i Capacity for RA synthesis from RA precursors (ROL,
RE) indicated either by direct (RA-reporter assay) or
indirect (neuronal differentiation in ROL or RE
containing medium; activation of direct RA-
responsive genes) evidences (Fig. 3, Fig. 9,
Supplementary Fig. S1)
ii Expression of ROL/RA binding (Rbp4, CrbpI, CrabpII)
and RA synthesizing protein (Rdh10 and Raldh)
mRNAs (Fig. 4, Fig. 5, Fig. 6)
iii The lack of Raldh2 expression in non-committed cells
(Fig. 5)
iv Expression of a broad panel of RA receptor mRNAs
(Fig. 8)
Differences
i Higher RA production by RGl cells (Fig. 3)
ii Retinoids induce extensive neuronal differentiation of
NE-4C neural stem cells but not of RGl progenitors
(Fig. 9, Supplementary Fig. S1)
iii Pan-RAR antagonist prevents neuronal differentiation
of NE-4C neural stem cells but not of RGl
progenitors (Fig. 9)
iv Lack or very low level expression of enzymes
responsible for vitamin A uptake (Stra6) and storage
(Lrat) in RGl cells (Fig. 4)
v Lack or low level expression of enzymes responsible
for RA catabolism (Cyp26) in RGl cells (Fig. 7)
vi Fewer retinoid pathway related genes are induced
during differentiation of RGl cells (7/20) compared
to NE-4C cells (13/20)* (Figs. 4–8)
Statements are based on detailed data on RA responsiveness, RA
production, and retinoid machinery of NE-4C and RGl neural stem/
progenitor cells.
*7/20 and 13/20: the number of genes showing alteration in
expression upon differentiation/total number of genes investigated.
RE, retinyl ester; ROL, retinol; RA, retinoic acid; RAR, RA receptor.
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conditions, could undergo neuronal differentiation upon EGF
removal. The RA-production by RGl cells, however, seemed
to depend on exogenous retinoid resources, which may be
explained by the lack of Lrat expression resulting in a missing
capacity to transform retinoids to the stored RE form. The lack
or very low level expression of the ROL transporter Stra6
mRNA in RGl cells suggested the involvement of alternative
retinoid uptake mechanisms [52,53]. Interestingly, mRNA for
the extracellular ROL carrier (Rbp4) was present in both NE-
4C and RGl cells regardless of the stage of their development.
Rbp4 expression may contribute to the regulation of vitamin
A availability in the proximate environment of neural
stem/progenitor cells [27,28] or developing/mature neurons
[43,54].
Both retinoid sensitivity and production by differenti-
ating neural stem cells highly depend on the cellular
composition of the cultures. In NE-4C cells, glial differ-
entiation was negligible in the investigated period [29].
Accordingly, the presented data reflect mainly the features
of neuronal progenies of NE-4C cells. However, in RGl
cells, the contribution of glial cells to the observed changes
in both RA production and the retinoid machinery has to
be taken into account. In mammals, many adult neu-
ral stem cells belong to GFAP-positive populations [55,
56], and our adult-derived RGl clones also show GFAP-
immunoreactivity [35]. Infinite serum-free, EGF-dependent
proliferation, spindle-shaped morphology and ready neu-
ron formation upon EGF withdrawal distinguishes RGl
cells from mature astrocytes. GFAP-positive, flattened as-
trocytes; however, appear in differentiated cultures of both
embryonic and adult RGl cells [35]. Their contribution to
the retinoid metabolism can hardly be assessed. Differences
in Gfap expression, in the level of RA production together
with opposite changes in Stra6, Lrat, Raldh1 and Raldh2
expressions show a nonidentical cellular composition of
differentiating cultures of embryonic and adult-derived
RGl cells.
Our results presented here outline distinct features of
retinoid metabolism in different neural stem cell populations.
The highly retinoid-sensitive NE-4C neural stem cells can
run the complete retinoid machinery and seem to regulate
their own differentiation via autocrine or cell-autonomous
RA signalling. The high sensitivity and low endogenous
RA-levels, however, imply that small disturbances in ex-
tracellular retinoid supply or intrinsic RA metabolism can
modulate cell-fate determining processes. As a contrast, the
high RA-production of RGl cells is disconnected from im-
mediate cell-fate decisions. The role and developmental sig-
nificance of active retinoids generated by these cells are to be
determined.
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